Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China flag China · Delayed Price · Currency is CNY
8.57
-0.19 (-2.17%)
May 20, 2026, 11:29 AM CST

SHA:600867 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,0072,9111,9762,9302,7423,219
Other Revenue
36.4136.4133.15145.8136.4749.22
3,0432,9472,0103,0752,7783,268
Revenue Growth (YoY)
47.04%46.66%-34.66%10.69%-14.98%12.99%
Cost of Revenue
898.51886.21547.46621.05628.13586.99
Gross Profit
2,1452,0611,4622,4542,1502,681
Selling, General & Admin
1,3071,2891,2511,0471,1141,255
Research & Development
165.3167.1299.3104.96146.71166.86
Other Operating Expenses
25.6926.4913.1411.6514.5711.27
Operating Expenses
1,4941,4791,3481,1841,2681,435
Operating Income
650.63582.23114.51,270882.291,246
Interest Expense
-21.81-21.81-14.38-5.17-0.28-
Interest & Investment Income
1,1691,183130.83103.61942.66304.32
Currency Exchange Gain (Loss)
-0.63-0.630.70.4700.24
Other Non Operating Income (Expenses)
-1.97-0.662.68-1.65-0.880.33
EBT Excluding Unusual Items
1,7951,743234.341,3681,8241,550
Gain (Loss) on Sale of Investments
0.620.220.40.520.96-0.37
Gain (Loss) on Sale of Assets
-85.74-85.26-239.83-3.13-0.11-13.48
Asset Writedown
-177.44-177.44-80.68-7-1.74-11.53
Legal Settlements
---60.82---
Other Unusual Items
-2.9-2.94.327.916.629.35
Pretax Income
1,5291,477-142.281,3661,8301,534
Income Tax Expense
317.5280.05-99.55197.97247.69225.86
Earnings From Continuing Operations
1,2121,197-42.731,1681,5821,309
Minority Interest in Earnings
24.821.860.77-0.090.06-0.34
Net Income
1,2371,219-41.951,1681,5821,308
Net Income to Common
1,2371,219-41.951,1681,5821,308
Net Income Growth
----26.17%20.92%40.69%
Shares Outstanding (Basic)
2,0401,9662,0981,9792,0022,044
Shares Outstanding (Diluted)
2,0401,9662,0981,9792,0022,044
Shares Change (YoY)
-1.21%-6.27%5.98%-1.15%-2.04%1.12%
EPS (Basic)
0.610.62-0.020.590.790.64
EPS (Diluted)
0.610.62-0.020.590.790.64
EPS Growth
----25.32%23.44%39.13%
Free Cash Flow
322.61171.53-106.4513.4370.21579.62
Free Cash Flow Per Share
0.160.09-0.050.260.180.28
Dividend Per Share
0.3000.3000.2500.2500.5000.300
Dividend Growth
20.00%20.00%--50.00%66.67%42.86%
Gross Margin
70.48%69.93%72.76%79.81%77.39%82.04%
Operating Margin
21.38%19.75%5.70%41.31%31.75%38.12%
Profit Margin
40.63%41.36%-2.09%37.97%56.93%40.03%
Free Cash Flow Margin
10.60%5.82%-5.29%16.69%13.32%17.74%
EBITDA
931.51844.5302.311,4561,0331,389
EBITDA Margin
30.61%28.65%15.04%47.35%37.20%42.51%
D&A For EBITDA
280.88262.27187.81185.87151.17143.65
EBIT
650.63582.23114.51,270882.291,246
EBIT Margin
21.38%19.75%5.70%41.31%31.75%38.12%
Effective Tax Rate
20.76%18.96%-14.49%13.54%14.72%
Revenue as Reported
2,9472,9472,0103,0752,7783,268
Advertising Expenses
-74.4393.2463.5946.79143.61
Source: S&P Global Market Intelligence. Standard template. Financial Sources.